Join
Live feed
·
INSIDERFilingvia Quantisnow
Revolution Medicines Inc. logo

SVP & General Counsel Cislini Jeff sold $670,631 worth of shares (3,366 units at $199.24) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 52,541 units (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
RVMD· Revolution Medicines Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RVMD (Revolution Medicines Inc.) and more on Quantisnow.